Ken Fisher Theratechnologies Inc. Transaction History

Fisher Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$3.28 - $4.07 $65,600 - $81,400	-20,000 Reduced 49.77%	20,183 $76,000
Q4 2020 Jan 29, 2021	SELL	$1.91 - $2.5 $38,964 - $51,000	-20,400 Reduced 33.67%	40,183 $100,000
Q3 2020 Nov 10, 2020	SELL	$1.96 - $2.92 $13,720 - $20,440	-7,000 Reduced 10.36%	60,583 $134,000
Q2 2020 Aug 07, 2020	SELL	$1.58 - $2.86 $9,480 - $17,160	-6,000 Reduced 8.15%	67,583 $136,000
Q3 2018 Oct 24, 2018	SELL	$6.56 - $9.8 $16,400 - $24,500	-2,500 Reduced 3.29%	73,583 $496,000
Q2 2018 Jul 09, 2018	BUY	$7.09 - $11.24 $272,326 - $431,728	38,410 Added 101.96%	76,083 $732,000
Q3 2017 Oct 17, 2017	BUY	$5.64 - $6.24 $212,475 - $235,079	37,673	37,673 $228,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $114M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.